Analgesics Market Report 2023-2028, Industry Growth, Key Players Analysis and Forecast

How Big is the Analgesics Market ? :

According to the latest report by IMARC Group, titled "Analgesics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", the global analgesics market size reached US$ 51.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 67.4 Billion by 2028, exhibiting a growth rate (CAGR) of 4.3% during 2023-2028.

Analgesics Uses:

Analgesics are a class of medications primarily designed to relieve pain. They encompass a wide range of over-the-counter and prescription drugs that help alleviate various types of pain, from mild headaches to chronic conditions. They work by interacting with the body's pain receptors or interrupting pain signals to the brain, providing temporary relief without addressing the underlying cause of pain. Common analgesics include non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, acetaminophen (paracetamol), and opioids for severe pain. Analgesics are crucial in enhancing the quality of life for individuals dealing with pain.

Request to get the sample report:https://www.imarcgroup.com/analgesics-market/requestsample

Competitive Landscape with Key Players:

• Bayer AG
• Novartis AG
• GlaxoSmithKline PLC
• Pfizer Inc.
• Johnson & Johnson
• Reckitt Benckiser (RB)
• Endo Pharmaceuticals
• Bristol-Myers Squibb
• Eli Lilly and Company
• Sanofi

Global Analgesics Market Trends:

The global market is majorly driven by the increasing prevalence of chronic pain conditions, such as arthritis and back pain. With aging populations and sedentary lifestyles becoming more common, there's a growing need for effective pain relief. Furthermore, the expanding availability of over-the-counter (OTC) analgesics is contributing to market growth. Consumers seek convenient access to pain relief options, and OTC analgesics like ibuprofen and acetaminophen provide readily available solutions. Moreover, the rising healthcare awareness and self-medication trends have led individuals to proactively manage minor ailments with analgesics, further boosting market expansion.

Besides, pharmaceutical advancements are introducing innovative analgesic formulations with improved efficacy and fewer side effects, attracting both patients and healthcare providers. Additionally, the opioid epidemic has spurred efforts to find safer alternatives for pain management, leading to increased research and development in non-opioid analgesics.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=1138&flag=C

Key Market Segmentation:

Breakup by Type:

• Prescription
• Over the counter (OTC)

Breakup by Drug Class:

• Opioids
• NSAID
• Others

Breakup by Route of Administration:

• Oral
• Parenteral
• Topical
• Transdermal
• Rectal

Breakup by Pain Type:

• Musculoskeletal
• Surgical and Trauma
• Cancer
• Neuropathic
• Migraine
• Obstetrical
• Fibromyalgia
• Pain due to Burns
• Dental/Facial
• Pediatric
• Others

Breakup by Application:

• Internal
• External
Breakup by Region:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

• Market Performance
• Market Outlook
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Related Report By IMARC Group:

• https://www.einnews.com/pr_news/622308674/pharmacy-benefit-management-market-to-grow-at-cagr-of-5-65-during-2023-2028

• https://www.einnews.com/pr_news/622304125/health-and-wellness-market-to-reach-a-value-of-us-4-454-0-billion-by-2028-cagr-of-3-99

• https://www.einnews.com/pr_news/622310883/geriatric-care-services-market-to-reach-us-1-682-billion-by-2028-growth-rate-cagr-of-7-3

• https://www.einnews.com/pr_news/627544483/active-pharmaceutical-ingredients-api-market-size-to-reach-us-303-9-billion-by-2028

• https://www.einpresswire.com/article/625819223/home-healthcare-market-analysis-2023-2028-top-companies-growth-and-business-opportunities

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.